Why does MRNA always make people want to chase but not dare to chase?

The charm of Moderna lies precisely in the fact that it leaves people conflicted. It has the imagination of biotech, as well as the risk of high volatility; it has stories from its R&D pipeline, as well as the market’s scrutiny of its ability to deliver. In TradFi trading, this kind of stock is especially likely to attract funds from those who “want to get the meat but are afraid of burning their mouths.”

Its stock performance is often highly tied to catalysts. As long as the market believes there will be new products, new indications, and new partnerships in the future, capital is willing to give it an even greater space for imagination. But if the catalysts aren’t strong enough, the valuation can quickly return to reality. In other words, trading MRNA follows an event-driven logic rather than a linear logic.

So this stock is best written as a representative of “high elasticity, high expectations, and high volatility.” For platforms, this kind of content naturally spreads because it can satisfy readers’ curiosity about opportunities while also reminding everyone that risks coexist with them. Most importantly, it’s easy to capture the reading psychology of “knowing there is danger, yet still can’t help wanting to take a look.” #TradFi交易分享挑战